NTR neurotrophin receptor has been implicated in multiple biological and pathological processes. While significant advances have recently been made in understanding the physiologic role of p75 NTR , many details and aspects remain to be determined. This is in part because the two existing knockout mouse models (Exons 3 or 4 deleted, respectively), both display features that defy definitive conclusions. Here we describe the generation of mice that carry a conditional p75 NTR (Barker, 2004; Lim et al., 2008) . Some of the functions of p75 NTR likely involve the proteolytic cleavage of its extracellular domain by metalloproteases followed by cleavage of the transmembrane domain by g-secretase (Bronfman, 2007) . This results in the production of an intracellular fragment that translocates to the nucleus and participates in transcriptional events.
The p75 neurotrophin receptor (p75 NTR ) is a transmembrane protein composed of an extracellular domain containing several cysteine-rich motifs, a transmembrane domain, and a non-catalytic intra-cellular domain (Underwood and Coulson, 2008) . It can interact with multiple different ligands and co-receptors and has been implicated in the regulation of a myriad cellular process including survival, neurite outgrowth and myelinization (Roux and Barker, 2002) . p75 NTR can bind all four neurotrophins and can also enhance signal transduction by Trk tyrosine kinase receptors in response to neurotrophins via a mechanism that is not fully understood (Underwood and Coulson, 2008) . Moreover, p75 NTR can form a molecular complex with the Nogo receptor and transduce myelin inhibitory signals, and associate with ephrin-A receptors and communicate reverse EphA signaling (Barker, 2004; Lim et al., 2008) . Some of the functions of p75 NTR likely involve the proteolytic cleavage of its extracellular domain by metalloproteases followed by cleavage of the transmembrane domain by g-secretase (Bronfman, 2007) . This results in the production of an intracellular fragment that translocates to the nucleus and participates in transcriptional events.
To address the role of p75 NTR in vivo, Lee et al. generated a knockout mouse by deleting Exon 3, which encodes part of the extracellular domain (Lee et al., 1992) . Homozygote mice are viable and fertile, and do not show any obvious external phenotypes. However, they display several defects in the nervous system, such 0 -GGGTGGAAGCTGGGACTGTGCACATGC-3 0 ) and template DNA from the putative correctly targeted clones (b) demonstrate that the clones #15 and #53 had retained the 5 0 loxP site. The wild type allele produces a 574-bp amplification product. Since the strategy to insert the 5 0 loxP sites into Intron 3 involved the generation of a 207-bp deletion, the mutant allele gives rise to a 407-bp amplification product. (d) Verification of the correct targeting using Southern blot analysis. Genomic ES cell DNAs were digested with BamHI and EcoRI and probed with the external probe (red bar in a). Correctly targeted clones #15 and #53 display both the wild-type and targeted alleles of 7.4 and 5.9 kb, respectively, while the non-targeted clones #18 and #87 show only the wild-type allele (7.4 kb). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] as impaired innervation by peripheral sensory neurons and decreased sensitivity to NGF (Lee et al., 1994a,b) . Subsequently, von Schack et al. showed that p75
NTRDExon3 encodes an alternatively spliced isoform, which is apparently present both in wildtype and in homozygote p75
NTRDExon3 mice (von Schack et al., 2001) . Reasoning that this isoform was able to support some signaling activity, these investigators generated another p75 mouse line that lacks sequences encoded by Exon 4 (p75 NTRDExon4 ) (von Schack et al., 2001) . The p75 NTRDExon4 mice display more severe defects than p75
NTRDExon3 mutants: about 40% of them die during the late fetal or early postnatal period, and showed defects in the descending aorta. The surviving mice are growth-retarded during the first weeks of life, and have abnormal reflexes and impaired motility caused by hind limb ataxia. It was later shown that the p75 NTRDExon4 mutants express an intracellular fragment of p75 NTR that has pro-apoptotic properties (Paul et al., 2004) . In summary, two different mutant mouse strains deficient in p75 NTR have been developed which illuminated new functions of the receptor in vivo (Lee et al., 1992; von Schack et al., 2001) . Unfortunately, interpretation of the phenotypes of these mutant strains is complicated by NTR protein is present in wild-type (Wt) brain and liver tissues, while knockout (KO) tissues do not display any detectable protein (arrow points to the p75 NTR protein band). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] novel and unanticipated molecular signals. Thus, additional mutant mouse strains are required to clarify the debate about the various functions of p75 NTR . We generated such a novel mouse line carrying a conditional knockout allele for p75 NTR (p75 NTR-FX/FX ) to investigate its functions in specific cells and tissues in vivo. The allele was designed such that a complete and conditional knockout can be achieved without the molecular complexities observed in mice with either the p75
NTRDExon3 (von Schack et al., 2001) or the p75 NTRDExon4 allele (Paul et al., 2004) . Our strategy was to flank Exons 4-6, which encodes the transmembrane and cytoplasmic domains, by loxP sites. The short (1.6 kb) and long (8.6 kb) arms of the targeting vector were PCR amplified from a Bac genomic DNA. A single loxP site was inserted into Intron 3 and the loxPNeoloxP cassette was inserted into the 3 0 sequence following the last Exon 6 (see Fig. 1 ). As a negative selection marker we used the diphteria toxin (DT) gene. The linearized targeting vector was electroporated into TVB2 embryonic stem cells as described (Yang and Kaartinen, 2007) . Five out of 150 G418-resistant colonies showed locus-specific integration (Fig. 1b) . Subsequent PCR and Southern assays confirmed that 2 of them contained the distant 5 0 loxP site (Fig. 1c,d ). Both correctly targeted ES clones were able to produce highly chimeric male mice, which were potent germline transmitters. To remove the Neo selection marker and to generate a presumed knockout allele for p75 NTR , we crossed the p75 NTR-FXNeo/FXNeo mice (homozygotes for the targeting vector) with EIIa-Cre transgenic mice (Holzenberger et al., 2000; Xu et al., 2001) . The obtained mosaic male progeny were subsequently crossed with wild-type female mice to obtain floxed (p75 NTR-FX ) and null (p75
NTR-KO
) allele-carrying mouse lines (Fig. 2a) . Homozygote p75 NTR-FX/FX mice were viable and fertile, and did not display any overt phenotypes.
To confirm that the p75 NTR-KO allele encoded a true null allele and to provide initial information about the biological role of p75 NTR , we inter-crossed the heterozygote p75 NTR-KO/WT mice to obtain homozygote p75 NTR-KO/KO mice. Genotype analyses of newborn offspring showed the expected Mendelian ratio of wildtype (p75 NTR-WT/WT ), heterozygotes (p75 NTR-KO/WT ), and homozygotes (p75 NTR-KO/KO ) consistent with viability of the p75 NTR-KO/KO at birth (n 5 63). RT-PCR using primers with target sequences in Exons 4 and 6 of brain and liver samples confirmed that the knockout allele did not produce any detectable amplification product, while the wild-type control showed the expected 210-bp fragment (Fig. 2b) . Immunoblotting using an antibody which recognizes the cytoplasmic domain of p75 NTR confirmed the absence of a p75 NTR gene product in p75 NTR-KO/KO mice (Fig. 2c) . Homozygote p75 NTR-KO/KO mice showed notable growth retardation during the first weeks of life, but subsequently recovered so that by the age of 10 weeks the size difference between p75 NTR mutants and controls was eliminated (Fig. 3a,b) . Starting at about three weeks of age, p75 NTR null mutants displayed signs of neuropathic phenotypes. When suspended by the tail, they clenched their hind limbs under their body, while the controls displayed the normal behavior of spreading out their hind limbs and toes (Fig. 5a,b) .
Since p75 NTR is strongly expressed in migrating neural crest cells (NCCs), we generated tissue-specific p75 NTR mutants by crossing p75 NTR-FX/FX mice with transgenic Wnt1-Cre driver mice, which are known to be able to induce a robust recombination in early migratory NCCs (Chai et al., 2000; Jiang et al., 2000) . Tissuespecific p75 NTR /Wnt1-Cre mutants were born in the expected Mendelian numbers and did not display subsequent growth retardation as observed in conventional p75 NTR mutants. Lack of p75 protein in the Wnt1 recombination domain was confirmed by p75 NTR immunostaining. As shown in Figure 4 , p75 NTR was specifically ablated in the dorsal root ganglia (derived from NCCs), while its expression in the lateral motor column was unaffected at E10. p75 NTR /Wnt1-Cre mutants displayed an abnormal hind limb ''clenching'' phenotype similar to that seen in conventional p75 NTR mutants suggesting that this common neuropathic phenotype was at least in part due to the impaired function of p75 NTR specifically in neural crest cells (Fig. 5c,d) . Previous studies have shown that sciatic nerves are abnormal in both p75
NTRDExon3 and p75 NTRDExon4 mutants (von Schack et al., 2001) . Concordant with these findings, the sciatic nerves in p75 NTR-KO/KO mice showed about a 30% reduction in diameter when compared to those of control littermates (Fig. 5e-g ). In addition, there were far fewer small diameter axon bundles in the mutant nerves than in control nerves suggesting that p75 mutants may suffer from defects in nociceptive sensory inputs, which are mostly unmyelinated and lightly-myelinated small diameter axons (Fig. 5h,i) .
Van Schack et al. have reported that the homozygous p75
NTRDExon3 mutants are born with expected Mendelian frequency, but about 40% of corresponding p75
NTRDExon4 mutant mice die during the perinatal period and suffer from pronounced vascular defects (von Schack et al., 2001 ). Here we show that deletion of the transmembrane and the entire cytoplasmic domain from the p75 NTR gene does not lead to late gestational, perinatal, or neonatal lethality. Neither could we detect vasodilatation phenotype in the dorsal aorta comparable to that seen in p75 NTRDExon4 mutants (data not shown). Instead our present studies demonstrate that at least some of the neurological phenotypes result from the need for functional p75 NTR in the neural crest cell lineage, while a role for p75 NTR in non-neural crest is implied by retardation in postnatal growth in systemic but not Wnt1-Cre-driven conditional mutants. Whether the more severe phenotype in p75 NTRDExon4 mutants when compared either to p75 NTRDExon3 mutants or to p75 NTR/KOKO mutants described in this article results from a production of an aberrant pro-apoptotic peptide as previously suggested (Paul et al., 2004) , from background differences or from other currently unknown reasons remains to be shown.
The mutant p75 NTR/KO allele described here does not produce a detectable protein product. Therefore, future studies using this allele will not be hampered by complexities associated with the use of the p75 NTRDExon3 allele, which produces an alternatively spliced product (von Schack et al., 2001) , or with the use of the p75 NTRDExon4 allele, which expresses an aberrantly proapoptotic peptide (Paul et al., 2004) . Similarly, the recently described p75 NTR conditional allele, in which Exon 3 was flanked by loxP sites (Lim et al., 2008) , can be expected to produce a similar alternative splicing variant as described for the corresponding conventional knockout allele (Lee et al., 1992) . However, Cre-mediated recombination of the p75 NTR-FX conditional allele described here leads to a complete inactivation of the p75 NTR gene. Recent studies have shown that expression levels of p75 NTR undergo dynamic changes during tissue injury and regeneration (Peterson and Bogenmann, 2003; Tomita et al., 2007) , but the detailed role of p75 NTR in these processes is currently unknown. The novel mouse line described here opens new opportunities to address tissue and cell type-specific roles of p75 NTR in physiologic and pathologic conditions.
METHODS

Generation of Mice Carrying the Floxed and Knockout p75 NTR Alleles
The long arm of the targeting vector containing the loxP site in Intron 3 was prepared as follows: A short (about 1.6 kb) SalI-EcoRI 5 0 fragment and a long (about 7 kb) BamHI-SacII 3 0 fragment were PCR amplified using RP23-67E18 Bac as a template. These fragments were subcloned and a single loxP site was inserted between the EcoRI and BamHI sites. The large (about 8.7 kb) 5 0 arm containing a loxP site in Exon 3 was then isolated as a single SalI-SacII fragment. The short, 3 0 , arm was amplified using RP23-67E18 Bac as a template as a single XhoI-ClaI fragment. High-fidelity Supermix (Qiagen) polymerase was used for amplification, and the generated arms were sequenced to verify that no PCR-generated mutations had been introduced. The targeting vector was assembled by first subcloning the PGK-Neo cassette flanked by loxP sites as a KpnI-BglII fragment into pKODT digested with KpnI-BamHI. Next the long SalI-SacII fragment (the long arm) containing the loxP site in Intron 3 was added into loxP-PGK-NeoloxP/pKODT and finally the short arm was added into the construct as a ClaI-XhoI fragment. The targeting vector was electroporated into TVB2 mouse ES cells, and recombinant ES cell clones were selected with G418 as described (Dudas et al., 2004; Kaartinen et al., 1995) . Mouse chimeras were generated by injecting correctly targeted ES clones into C57BL/6J mouse blastocysts. The floxed p75 NTR allele (p75 NTR-FX ) and the knockout p75 NTR allele (p75
NTR-KO
) were generated by crossing female mice homozygous for the targeting vec- tor with EIIa-Cre transgenic male mice (Xu et al., 2001) . Both EIIa-Cre and Wnt1-Cre mice were from The Jackson Laboratories (Maine).
PCR Screening, Clone Verification, and Genotyping ES cell DNAs were first screened for correct targeting by PCR using a forward primer (a 0 ) 5 0 -GGGGATCCG CTGTAAGTCTGCA-3 0 and a reverse primer (b 0 ) 5 0 -TGGGGGAGGGGTGGCTAATTT-3 0 . Subsequently, presence of the single loxP site in Intron 4 was verified by PCR using a forward primer (a) 5 0 -CCTCCGCCAGCT GTCTGCTTCCT-3 0 and a reverse primer (b) 5 0 -GGGTGG AAGCTGGGACTGTGCACATGC-3 0 . p75 NTR-FX mice were genotyped using forward and reverse primers (c) 5 0 -TGCAGAAATCATCGACCCTTCCC-3 0 and (d) 5 0 -TCCTCA CCCCGTTCTTTCCCC-3 0 , respectively, while p75 NTR-KO mice were genotyped using forward (a) and reverse primers (d). Southern blot analyses of genomic DNAs digesting with BamHI and EcoRI were used to confirm homologous recombination using an external probe, which recognizes sequences encoded by Exon 3 (see Fig. 1 ).
Timed Matings and Embryo Generation
Mice were maintained on a daily twelve hour light cycle and female mice checked for vaginal plugs twice a day. The day on which a female mouse acquired a vaginal plug was designated as day (''E'') 0. For the required embryonic stages, pregnant females were euthanized by CO 2 after the appropriate number of days and embryos were recovered for analysis. All studies and procedures performed on mice were carried out at the Animal Care Facility of the School of Dentistry (ULAM), University of Michigan-Ann Arbor, and were approved by the University of Michigan Animal Care and Use Committee (UCUCA). The mice were maintained in mixed genetic backgrounds.
RT-PCR
Total RNA was isolated from E8 embryos (RNeasy mini kit, Qiagen), and cDNAs synthesized (Omniscript reverse transcription kit, Qiagen) according to manufacturer's protocols. cDNAs were analyzed by PCR for p75 NTR expression using the following primer pairs. bactin was used as a quality and loading control. 
Western Blotting
Brain and liver tissues were harvested from three week old control and mutant mice, and lysed in 23 Laemmli sample buffer (Harlow and Lane, 1988) . About 10 lg of protein per lane was resolved on NuPAGE BisTris SDS PAGE gels (Invitrogen) using the X-Cell SureLock Mini-Cell electrophoresis system (Invitrogen) and electroblotted onto PVDF membrane (Invitrogen). The membrane was blocked and incubated overnight at 48C with anti-p75 NTR antibody (Millipore). The membrane was then probed with horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody and visualized with ECL reagents (Immobilon Western, Millipore). The chemiluminescent signal was recorded using the BioSpectrum AC Imaging system (UVP).
Immunohistochemistry
Embryos (E10) were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) at 48C for 1 h, dehydrated, cleared in toluene, and embedded in paraffin. Serial 7-lm-thick transverse sections were mounted on Superfrost Plus slides (Fisher Scientific). After epitope recovery by proteinase K digestion (20 lg ml 21 for 6 min at room temperature), sections were incubated with anti-p75 NTR rabbit anti-mouse primary antibody (Advanced Targeting Systems) at 1:200 dilution at 48C overnight followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen) secondary antibody labeling. Vectashield mounting medium with DAPI for fluorescence (Vector Laboratories) was used for mounting slides and staining nuclei. The results were examined and recorded on an Olympus BX51 microscope and photographed using a DP71 camera and DP controller software (Olympus).
Sciatic Nerve Analysis
Postnatal 1-to 3-month-old control and mutant mice were perfused with 4% paraformaldehyde and the left and right sciatic nerves dissected. Semithin plastic sections were prepared and stained with toluidine blue. Mosaic images of entire cross sections of sciatic nerve from comparable anatomic levels were collected using a microscope with a motorized stage (Axiovert 200M, Zeiss) . The diameter of the sciatic nerves were measured and compared between mutant and control mice using the analysis software (Axiovision, Zeiss). The data are displayed as the mean 6 SEM of four nerves from each genotype. The data were subjected to a student's ttest and a P-value <0.05 was considered significant.
